The use of water-soluble bioflavonoid-ascorbic acid complex in the treatment of recurrent herpes labialis

G. T. Terezhalmy, W. K. Bottomley, G. B. Pelleu

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

The efficacy of a water-soluble bioflavonoid-ascorbic acid complex was evaluated in the treatment of fifty episodes of recurrent herpes labialis. Twenty episodes were treated with a complex of 600 mg. of water-soluble bioflavonoids and 600 mg. of ascorbic acid, administered in equal increments three times daily. Twenty episodes were treated with a complex of 1,000 mg. of water-soluble bioflavonoids and 1,000 mg. of ascorbic acid, administered in equal increments five times daily. Ten episodes were treated with a lactose placebo. The therapeutic regimen was maintained for 3 days after the recognition of the initial symptoms associated with recurrent herpes labialis. The water-soluble bioflavonoid-ascorbic acid complex was observed to reduce vesiculation and to prevent the disruption of the vesicular membrane. The therapeutic measure was found to be most effective when initiated during the prodromal stage of the disease process. Optimum remission of symptoms was observed in 4.2 ± 1.7 days with the 600 mg. dosage of the water-soluble bioflavonoid-ascorbic acid complex. No adverse reactions were reported by any of the patients who participated in this investigation.

Original languageEnglish (US)
Pages (from-to)56-62
Number of pages7
JournalOral Surgery, Oral Medicine, Oral Pathology
Volume45
Issue number1
DOIs
StatePublished - Jan 1978

    Fingerprint

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dentistry(all)

Cite this